SETILEUTON

ID: ALA2105653

Chembl Id: CHEMBL2105653

Cas Number: 910656-27-8

PubChem CID: 11856170

Max Phase: Phase

Molecular Formula: C22H17F4N3O4

Molecular Weight: 463.39

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: MK-0633 | SETILEUTON|910656-27-8|MK-0633|0U2750935P|4-(4-fluorophenyl)-7-[[[5-[(2S)-1,1,1-trifluoro-2-hydroxybutan-2-yl]-1,3,4-oxadiazol-2-yl]amino]methyl]chromen-2-one|(S)-4-(4-fluorophenyl)-7-(((5-(1,1,1-trifluoro-2-hydroxybutan-2-yl)-1,3,4-oxadiazol-2-yl)amino)methyl)-2H-chromen-2-one|2H-1-Benzopyran-2-one, 4-(4-fluorophenyl)-7-(((5-((1S)-1-hydroxy-1-(trifluoromethyl)propyl)-1,3,4-oxadiazol-2-yl)amino)methyl)-|Setileuton [USAN]|Setileuton [USAN:INN]|UNII-0U2750935P|MK0633|MK 0633|SETILEUTON [Show More

Canonical SMILES:  CC[C@](O)(c1nnc(NCc2ccc3c(-c4ccc(F)cc4)cc(=O)oc3c2)o1)C(F)(F)F

Standard InChI:  InChI=1S/C22H17F4N3O4/c1-2-21(31,22(24,25)26)19-28-29-20(33-19)27-11-12-3-8-15-16(10-18(30)32-17(15)9-12)13-4-6-14(23)7-5-13/h3-10,31H,2,11H2,1H3,(H,27,29)/t21-/m0/s1

Standard InChI Key:  MAOIDRRXRLYJNV-NRFANRHFSA-N

Alternative Forms

  1. Parent:

    ALA2105653

    SETILEUTON

Associated Targets(Human)

ALOX5 Tclin Arachidonate 5-lipoxygenase (6568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cyp1a1 Cytochrome P450 1A1 (95 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cyp1a2 Cytochrome P450 1A2 (75 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cyp3a1 Cytochrome P450 3A1 (15 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cyp3a2 Cytochrome P450 3A2 (13 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (4459 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: YesAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 463.39Molecular Weight (Monoisotopic): 463.1155AlogP: 4.75#Rotatable Bonds: 6
Polar Surface Area: 101.39Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.91CX Basic pKa: CX LogP: 3.65CX LogD: 3.64
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.31Np Likeness Score: -0.79

References

1. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 
2. Maciolek CM, Ma B, Menzel K, Laliberte S, Bateman K, Krolikowski P, Gibson CR..  (2011)  Novel cytochrome P450-mediated ring opening of the 1,3,4-oxadiazole in setileuton, a 5-lipoxygenase inhibitor.,  39  (5): [PMID:21325431] [10.1124/dmd.110.037366]
3. Bruno F, Spaziano G, Liparulo A, Roviezzo F, Nabavi SM, Sureda A, Filosa R, D'Agostino B..  (2018)  Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma.,  153  [PMID:29133059] [10.1016/j.ejmech.2017.10.020]